StartupsFinSMEsabout 2 hours ago
Skopos Bio Raises $12M Seed Funding
1 min read
Skopos Bio, a Melbourne developer of nuclear-science-backed oncology therapies, raised $12m in seed funding on 12/10/2026. Backers included Tenmile, Tin Alley Ventures, and Yosemite. The company intends to use the funds to advance its research and development pipeline for targeted radioactive molecules and progress its initial therapeutic assets toward human clinical trials.
Level
Hype check
Tap to vote and see what everyone thinks.
